Embla Medical – Recording of Q2 2024 presentation
Today, Embla Medical's CEO Sveinn Solvason presented the Q2 2024 results, the expectations for the rest of the year, and details about Medicare's finalized proposal that grants access to more advanced solutions for more patients in the US.
Watch the recording here: https://www.inderes.dk/videos/embla-medical-presentation-of-interim-report-q2-2024
Embla Medical is a leading global provider of innovative mobility solutions in the medical technology space. Embla Medical improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and accompanying Patient Care. Headquartered in Iceland, the company employs over 4,000. Embla Medical has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.
Disclaimer: HC Andersen Capital receives payment from Embla Medical for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis, 17:22, 23 July 2024.
Embla Medical
Embla Medical is an Icelandic company active in health and medical care. The company's main focus is on the development of bone prostheses, osteoarthritis, and related injury management. The products are adapted for different ages and conditions depending on the patient's severity. Embla Medical is established globally with the largest market in Europe, followed by North America. The company was founded in 1971 and the head office is located in Reykjavik, Island.
Read more on company page